WURTH, ROBERTO
 Distribuzione geografica
Continente #
EU - Europa 3.582
Totale 3.582
Nazione #
IT - Italia 3.582
Totale 3.582
Città #
Genova 2.822
Genoa 344
Rapallo 210
Vado Ligure 196
Bordighera 10
Totale 3.582
Nome #
The histone demethylase KDM5A is a key factor for the resistance to temozolomide in glioblastoma 175
New molecules and old drugs as emerging approaches to selectively target human glioblastoma cancer stem cells 167
Peptide Receptor Targeting in Cancer: The Somatostatin Paradigm 157
Phenotypical and Pharmacological Characterization of Stem-Like Cells in Human Pituitary Adenomas 153
Cellular prion protein controls stem cell-like properties of human glioblastoma tumor-initiating cells 153
Inhibition of CXCL12/CXCR4 autocrine/paracrine loop reduces viability of human glioblastoma stem-like cells affecting self-renewal activity. 149
Inhibition of the Autophagy Pathway Synergistically Potentiates the Cytotoxic Activity of Givinostat (ITF2357) on Human Glioblastoma Cancer Stem Cells 143
Patient-derived xenograft in zebrafish embryos: a new platform for translational research in neuroendocrine tumors 137
Metformin repositioning as antitumoral agent: selective antiproliferative effects in human glioblastoma stem cells, via inhibition of CLIC1-mediated ion current 135
Receptor tyrosine kinase inhibitors and cytotoxic drugs affect pleural mesothelioma cell proliferation: insight into EGFR and ERK1/2 as antitumor targets 135
Drug design strategies focusing on the CXCR4/CXCR7/CXCL12 pathway in leukemia and lymphoma 134
Drug-repositioning opportunities for cancer therapy: Novel molecular targets for known compounds 133
Metformin inhibition of neuroblastoma cell proliferation is differently modulated by cell differentiation induced by retinoic acid or overexpression of NDM29 non-coding RNA 128
Inhibition of chloride intracellular channel 1 (CLIC1) as biguanide class-effect to impair human glioblastoma stem cell viability 123
Molecular pharmacology of malignant pleural mesothelioma: Challenges and perspectives from preclinical and clinical studies 122
Emerging targets in pituitary adenomas: role of the CXCL12/CXCR4-R7 system 120
Primary Cultures from Human GH-secreting or Clinically Non-functioning Pituitary Adenomas 117
Expression of CXCR7 chemokine receptor in human meningioma cells and in intratumoral microvasculature 110
Isolation of stem-like cells from spontaneous feline mammary carcinomas: phenotypic characterization and tumorigenic potential 109
The chemokine SDF1/CXCL12: a novel autocrine/paracrine factor involved in pituitary adenoma development 108
The inhibition of FGF receptor 1 activity mediates sorafenib antiproliferative effects in human malignant pleural mesothelioma tumor-initiating cells 108
Somatostatin receptor 1, 2 and 5 activation leads to C6 glioma growth arrest in vitro and in vivo: analysis of the intracellular pathways involved 104
Canine osteosarcoma cell lines contain stem-like cancer cells: Biological and pharmacological characterization 101
CXCL12 modulation of CXCR4 and CXCR7 activity in human glioblastoma stem-like cells and regulation of the tumor microenvironment 100
Balance between somatostatin and D2 receptor expression drives TSH-secreting adenoma response to somatostatin analogs and dopastatins 98
CXCR4 expression in feline mammary carcinoma cells: evidence of a proliferative role for the SDF-1/CXCR4 axis 98
Subventricular zone microenvironment protects glioblastoma cells from radiotherapy cytotoxicity: Role of the chemokine CXCL12 88
17{beta}-ESTRADIOL PROMOTES BREAST CANCER CELL PROLIFERATION INDUCING SDF-1-MEDIATED EGFR TRANSACTIVATION: REVERSAL BY GEFITINIB PRE-TREATMENT. 87
Experimental Evidence and Clinical Implications of Pituitary Adenoma Stem Cells 83
Metformin selectively affects human glioblastoma tumor-initiating cell viability: A role for metformin-induced inhibition of Akt 76
Stem-like signatures in human meningioma cells are under the control of CXCL11/CXCL12 chemokine activity 63
Totale 3.714
Categoria #
all - tutte 10.591
article - articoli 10.591
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 21.182


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020821 0 0 0 0 90 112 152 77 112 148 98 32
2020/2021412 22 41 37 34 65 17 28 25 17 68 33 25
2021/2022393 15 28 25 47 11 38 23 89 23 31 17 46
2022/2023259 21 17 4 30 24 50 0 29 38 1 36 9
2023/2024299 18 24 8 38 15 79 22 18 12 15 9 41
2024/2025203 25 47 25 52 54 0 0 0 0 0 0 0
Totale 3.714